Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07804615 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Name: A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy — clinical trial record (NCT07804615)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Vista PD

StatusNot Yet Recruiting

PhasePhase 2

SponsorVima Therapeutics

Started2026-09

View on ClinicalTrials.gov ↗

Vista PD is a randomized, placebo-controlled, multicenter study to evaluate the efficacy, PK, safety, and tolerability of VIM0423 in adults with Parkinson's disease tremor insufficiently responsive to dopaminergic therapy. The main objectives of this clinical trial are to determine the following: * Does VIM0423 therapy improve tremor symptoms in adults with Parkinson's disease? * Is VIM0423 well tolerated in individuals with Parkinsons's disease? and * Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?

Trial Details

NCT Number	NCT07804615
Lead Sponsor	Vima Therapeutics
Conditions	PARKINSON DISEASE (Disorder)
Enrollment	80 participants
Start Date	2026-09
Primary Completion	2027-06 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-09-04